Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
The current price of Pfizer Inc in the market is 91,38 zł, with a 24-hour trading volume of 3,28B zł. The asset's market cap is 519,59B zł, after moving -0.82% in the last day.
Tokenized Pfizer Inc is trading at 93,54 zł, with a tokenized market cap of 15,12M zł and a 24-hour trading volume of 223,07K zł. The tokenized asset has moved 0.32% in the past 24 hours.